Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 662

1.

Hepatic gluconeogenic response to single and long-term SGLT2 inhibition in lean/obese male hepatic G6pc-reporter mice.

Inaba Y, Hashiuchi E, Watanabe H, Kimura K, Sato M, Kobayashi M, Matsumoto M, Kitamura T, Kasuga M, Inoue H.

Endocrinology. 2019 Sep 13. pii: en.2019-00422. doi: 10.1210/en.2019-00422. [Epub ahead of print]

PMID:
31517956
2.

Diabetes care providers' manual for disaster diabetes care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

Diabetol Int. 2019 Jun 14;10(3):153-179. doi: 10.1007/s13340-019-00397-7. eCollection 2019 Jul.

PMID:
31275782
3.

Diabetes Care Providers' Manual for Disaster Diabetes Care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

J Diabetes Investig. 2019 Jul;10(4):1118-1142. doi: 10.1111/jdi.13053. Epub 2019 Jun 14.

4.

Analysis of the duration and extent of the legacy effect in patients with type 2 diabetes: A real-world longitudinal study.

Takao T, Matsuyama Y, Suka M, Yanagisawa H, Kasuga M.

J Diabetes Complications. 2019 Aug;33(8):516-522. doi: 10.1016/j.jdiacomp.2019.05.005. Epub 2019 May 10.

PMID:
31186162
5.

PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.

Yano H, Sakai M, Matsukawa T, Yagi T, Naganuma T, Mitsushima M, Iida S, Inaba Y, Inoue H, Unoki-Kubota H, Kaburagi Y, Asahara SI, Kido Y, Minami S, Kasuga M, Matsumoto M.

Sci Rep. 2018 Sep 24;8(1):14290. doi: 10.1038/s41598-018-32575-z.

6.

Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein.

Watanabe H, Inaba Y, Kimura K, Matsumoto M, Kaneko S, Kasuga M, Inoue H.

Nat Commun. 2018 Jan 2;9(1):30. doi: 10.1038/s41467-017-02537-6.

7.

Incorporation of an N-methyl Amino Acid into a Template Peptide Alters Anisotropy in the Crystal Growth of Gold Nanoparticles Synthesized by the Peptide Template Method.

Tomizaki KY, Nanbu R, Kasuga M, Imai T.

Protein Pept Lett. 2018;25(1):48-55. doi: 10.2174/0929866525666171214105611.

PMID:
29237363
8.

[Implementation and Evaluation of Genetic Testing Seminars about Lifestyle-related Disease Prevention in Pharmacy Insurance-The Need for Cooperation between the Pharmacy and the University in Genetic Testing].

Ikeda K, Kasuga M, Hosoi T, Yoshii M, Sugiyama M, Wako A, Ozawa K.

Yakugaku Zasshi. 2017;137(12):1517-1531. doi: 10.1248/yakushi.16-00243. Japanese.

9.

Acoustic monitoring to document the spatial distribution and hotspots of blast fishing in Tanzania.

Braulik G, Wittich A, Macaulay J, Kasuga M, Gordon J, Davenport TRB, Gillespie D.

Mar Pollut Bull. 2017 Dec 15;125(1-2):360-366. doi: 10.1016/j.marpolbul.2017.09.036. Epub 2017 Sep 27.

PMID:
28958441
10.

Osimertinib-Induced Interstitial Lung Disease Presenting as Eosinophilic Pneumonia.

Tachi H, Shiozawa T, Sakai C, Kasuga M, Nakazawa K, Morishima Y, Satoh H, Hizawa N, Sakashita S, Sekine I.

J Thorac Oncol. 2017 Aug;12(8):e118-e120. doi: 10.1016/j.jtho.2017.03.022. No abstract available.

11.

Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS).

Sugiyama T, Miyo K, Tsujimoto T, Kominami R, Ohtsu H, Ohsugi M, Waki K, Noguchi T, Ohe K, Kadowaki T, Kasuga M, Ueki K, Kajio H.

Diabetol Int. 2017 Jun 27;8(4):375-382. doi: 10.1007/s13340-017-0326-y. eCollection 2017 Nov.

12.

Erratum: Evaluation of the yield of abiotic-stress-tolerant AtDREB1A transgenic potato under saline conditions in advance of field trials.

Shimazaki T, Endo T, Kasuga M, Yamaguchi-Shinozaki K, Watanabe KN, Kikuchi A.

Breed Sci. 2017 Mar;67(2):172. doi: 10.1270/jsbbs.16054e. Epub 2017 Mar 4.

13.

Evaluation of the yield of abiotic-stress-tolerant AtDREB1A transgenic potato under saline conditions in advance of field trials.

Shimazaki T, Endo T, Kasuga M, Yamaguchi-Shinozaki K, Watanabe KN, Kikuchi A.

Breed Sci. 2016 Dec;66(5):703-710. doi: 10.1270/jsbbs.16054. Epub 2016 Oct 21. Erratum in: Breed Sci. 2017 Mar;67(2):172.

14.

New glycemic targets for patients with diabetes from the Japan Diabetes Society.

Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T.

J Diabetes Investig. 2017 Jan;8(1):123-125. doi: 10.1111/jdi.12600. Epub 2016 Dec 9.

15.

The GCN5-CITED2-PKA signalling module controls hepatic glucose metabolism through a cAMP-induced substrate switch.

Sakai M, Tujimura-Hayakawa T, Yagi T, Yano H, Mitsushima M, Unoki-Kubota H, Kaburagi Y, Inoue H, Kido Y, Kasuga M, Matsumoto M.

Nat Commun. 2016 Nov 22;7:13147. doi: 10.1038/ncomms13147.

16.

New glycemic targets for patients with diabetes from the Japan Diabetes Society.

Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T.

Diabetol Int. 2016 Nov 16;7(4):327-330. doi: 10.1007/s13340-016-0297-4. eCollection 2016 Dec. Review.

18.

Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report.

Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H.

Cancer Sci. 2016 Mar;107(3):369-71. doi: 10.1111/cas.12889. Review.

19.

Central Insulin Action Activates Kupffer Cells by Suppressing Hepatic Vagal Activation via the Nicotinic Alpha 7 Acetylcholine Receptor.

Kimura K, Tanida M, Nagata N, Inaba Y, Watanabe H, Nagashimada M, Ota T, Asahara S, Kido Y, Matsumoto M, Toshinai K, Nakazato M, Shibamoto T, Kaneko S, Kasuga M, Inoue H.

Cell Rep. 2016 Mar 15;14(10):2362-74. doi: 10.1016/j.celrep.2016.02.032. Epub 2016 Mar 3.

20.

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report.

Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H.

Diabetol Int. 2016 Mar 7;7(1):12-15. doi: 10.1007/s13340-016-0257-z. eCollection 2016 Mar. Review.

21.

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study.

Yasuda H, Hotta N, Kasuga M, Kashiwagi A, Kawamori R, Yamada T, Baba Y, Alev L, Nakajo K.

J Diabetes Investig. 2016 Jan;7(1):100-8. doi: 10.1111/jdi.12361. Epub 2015 May 18.

22.

[The Update of Obesity Syndrome: Molecular Mechanism. Pathophysiology and Therapies. Editorial: Obesity disease and its pathogenesis].

Kasuga M.

Nihon Naika Gakkai Zasshi. 2015 Apr 10;104(4):687-9. Japanese. No abstract available.

PMID:
26536729
23.

Establishment of maturity-onset diabetes of the young-induced pluripotent stem cells from a Japanese patient.

Yabe SG, Iwasaki N, Yasuda K, Hamazaki TS, Konno M, Fukuda S, Takeda F, Kasuga M, Okochi H.

J Diabetes Investig. 2015 Sep;6(5):543-7. doi: 10.1111/jdi.12334. Epub 2015 Mar 5.

24.

Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c.

Asahara S, Etoh H, Inoue H, Teruyama K, Shibutani Y, Ihara Y, Kawada Y, Bartolome A, Hashimoto N, Matsuda T, Koyanagi-Kimura M, Kanno A, Hirota Y, Hosooka T, Nagashima K, Nishimura W, Inoue H, Matsumoto M, Higgins MJ, Yasuda K, Inagaki N, Seino S, Kasuga M, Kido Y.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8332-7. doi: 10.1073/pnas.1422104112. Epub 2015 Jun 22.

25.

Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice.

Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, Kido Y, Matsumoto M, Yamamoto Y, Harada K, Kaneko S, Oyadomari S, Ozaki M, Kasuga M, Inoue H.

Hepatology. 2015 Apr;61(4):1343-56. doi: 10.1002/hep.27619. Epub 2015 Feb 23.

PMID:
25420998
26.

Glypican-4 is a new comer of adipokines working as insulin sensitizer.

Tamori Y, Kasuga M.

J Diabetes Investig. 2013 May 6;4(3):250-1. doi: 10.1111/jdi.12071. Epub 2013 Mar 26. No abstract available.

27.

Analysis of mitochondrial DNA HVR1 haplotype of pure-bred domestic dogs in Japan.

Sugiyama S, Chong YH, Shito M, Kasuga M, Kawakami T, Udagawa C, Aoki H, Bonkobara M, Tsuchida S, Sakamoto A, Okuda H, Nagai A, Omi T.

Leg Med (Tokyo). 2013 Nov;15(6):303-9. doi: 10.1016/j.legalmed.2013.08.005. Epub 2013 Sep 8.

PMID:
24120304
28.

Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer.

Kasuga M, Ueki K, Tajima N, Noda M, Ohashi K, Noto H, Goto A, Ogawa W, Sakai R, Tsugane S, Hamajima N, Nakagama H, Tajima K, Miyazono K, Imai K.

Cancer Sci. 2013 Jul;104(7):965-76. doi: 10.1111/cas.12203.

29.

Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique.

Takahashi E, Okumura A, Unoki-Kubota H, Hirano H, Kasuga M, Kaburagi Y.

J Proteomics. 2013 Jun 12;84:40-51. doi: 10.1016/j.jprot.2013.03.014. Epub 2013 Mar 29.

PMID:
23545169
30.

Histidine augments the suppression of hepatic glucose production by central insulin action.

Kimura K, Nakamura Y, Inaba Y, Matsumoto M, Kido Y, Asahara S, Matsuda T, Watanabe H, Maeda A, Inagaki F, Mukai C, Takeda K, Akira S, Ota T, Nakabayashi H, Kaneko S, Kasuga M, Inoue H.

Diabetes. 2013 Jul;62(7):2266-77. doi: 10.2337/db12-1701. Epub 2013 Mar 8.

31.

Ras-related C3 botulinum toxin substrate 1 (RAC1) regulates glucose-stimulated insulin secretion via modulation of F-actin.

Asahara S, Shibutani Y, Teruyama K, Inoue HY, Kawada Y, Etoh H, Matsuda T, Kimura-Koyanagi M, Hashimoto N, Sakahara M, Fujimoto W, Takahashi H, Ueda S, Hosooka T, Satoh T, Inoue H, Matsumoto M, Aiba A, Kasuga M, Kido Y.

Diabetologia. 2013 May;56(5):1088-97. doi: 10.1007/s00125-013-2849-5. Epub 2013 Feb 15.

32.

Metabolic profiling of transgenic potato tubers expressing Arabidopsis dehydration response element-binding protein 1A (DREB1A).

Iwaki T, Guo L, Ryals JA, Yasuda S, Shimazaki T, Kikuchi A, Watanabe KN, Kasuga M, Yamaguchi-Shinozaki K, Ogawa T, Ohta D.

J Agric Food Chem. 2013 Jan 30;61(4):893-900. doi: 10.1021/jf304071n. Epub 2013 Jan 16.

PMID:
23286584
33.

[Operative problems during simultaneous laparoscopic surgery for gastric and colorectal cancer].

Kasuga M, Komatsu S, Ichikawa D, Okamoto K, Shiozaki A, Fujiwara H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2351-3. Japanese.

PMID:
23268074
34.

Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism.

Takahashi M, Inomata S, Okimura Y, Iguchi G, Fukuoka H, Miyake K, Koga D, Akamatsu S, Kasuga M, Takahashi Y.

Endocr J. 2013;60(1):37-44. Epub 2012 Oct 13.

35.

[Concept of diabetes and its historical changes].

Kasuga M.

Nihon Rinsho. 2012 May;70 Suppl 3:9-13. Japanese. No abstract available.

PMID:
22768488
36.

Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance.

Kawano Y, Nakae J, Watanabe N, Fujisaka S, Iskandar K, Sekioka R, Hayashi Y, Tobe K, Kasuga M, Noda T, Yoshimura A, Onodera M, Itoh H.

Diabetes. 2012 Aug;61(8):1935-48. doi: 10.2337/db11-0770. Epub 2012 May 14.

37.

Relative importance of different surface regions for thermal comfort in humans.

Nakamura M, Yoda T, Crawshaw LI, Kasuga M, Uchida Y, Tokizawa K, Nagashima K, Kanosue K.

Eur J Appl Physiol. 2013 Jan;113(1):63-76. doi: 10.1007/s00421-012-2406-9. Epub 2012 May 9.

PMID:
22569893
38.

A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations.

Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, Takahashi A, Horikoshi M, Nakamura M, Fujita H, Tsunoda T, Kubo M, Watada H, Maegawa H, Okada-Iwabu M, Iwabu M, Shojima N, Ohshige T, Omori S, Iwata M, Hirose H, Kaku K, Ito C, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Kasuga M, Kamatani N; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, Nakamura Y, Kadowaki T.

Hum Mol Genet. 2012 Jul 1;21(13):3042-9. doi: 10.1093/hmg/dds113. Epub 2012 Mar 28.

PMID:
22456796
39.

CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.

Sakai M, Matsumoto M, Tujimura T, Yongheng C, Noguchi T, Inagaki K, Inoue H, Hosooka T, Takazawa K, Kido Y, Yasuda K, Hiramatsu R, Matsuki Y, Kasuga M.

Nat Med. 2012 Mar 18;18(4):612-7. doi: 10.1038/nm.2691.

PMID:
22426420
40.

Chemerin regulates β-cell function in mice.

Takahashi M, Okimura Y, Iguchi G, Nishizawa H, Yamamoto M, Suda K, Kitazawa R, Fujimoto W, Takahashi K, Zolotaryov FN, Hong KS, Kiyonari H, Abe T, Kaji H, Kitazawa S, Kasuga M, Chihara K, Takahashi Y.

Sci Rep. 2011;1:123. doi: 10.1038/srep00123. Epub 2011 Oct 19.

41.

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values.

Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H; Committee on the Standardization of Diabetes Mellitus‐Related Laboratory Testing of Japan Diabetes Society.

J Diabetes Investig. 2012 Feb 20;3(1):39-40. doi: 10.1111/j.2040-1124.2012.00207.x. No abstract available.

42.

[Novel treatment strategy using Trafermin® consisting of bFGF for intractable pancreatic fistula following gastrectomy for gastric cancer-a case report with literature reviews].

Kasuga M, Komatsu S, Ikoma H, Ichikawa D, Okamoto K, Shiozaki A, Fujiwara H, Murayama Y, Kuriu Y, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E.

Gan To Kagaku Ryoho. 2011 Nov;38(12):1966-8. Review. Japanese.

PMID:
22202254
43.

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.

Shim JH, Greenblatt MB, Singh A, Brady N, Hu D, Drapp R, Ogawa W, Kasuga M, Noda T, Yang SH, Lee SK, Rebel VI, Glimcher LH.

J Clin Invest. 2012 Jan;122(1):91-106. doi: 10.1172/JCI59466. Epub 2011 Dec 1. Erratum in: J Clin Invest. 2012 May 1;122(5):1948.

44.

Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation.

Kimura K, Yamada T, Matsumoto M, Kido Y, Hosooka T, Asahara S, Matsuda T, Ota T, Watanabe H, Sai Y, Miyamoto K, Kaneko S, Kasuga M, Inoue H.

Diabetes. 2012 Jan;61(1):61-73. doi: 10.2337/db10-1684. Epub 2011 Nov 28.

45.

KCNQ1, a susceptibility gene for type 2 diabetes.

Kasuga M.

J Diabetes Investig. 2011 Nov 30;2(6):413-4. doi: 10.1111/j.2040-1124.2011.00178.x. No abstract available.

46.

Ablation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in vascular endothelial cells enhances insulin sensitivity by reducing visceral fat and suppressing angiogenesis.

Tawaramoto K, Kotani K, Hashiramoto M, Kanda Y, Nagare T, Sakaue H, Ogawa W, Emoto N, Yanagisawa M, Noda T, Kasuga M, Kaku K.

Mol Endocrinol. 2012 Jan;26(1):95-109. doi: 10.1210/me.2010-0412. Epub 2011 Nov 22.

47.

Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1.

Koyanagi M, Asahara S, Matsuda T, Hashimoto N, Shigeyama Y, Shibutani Y, Kanno A, Fuchita M, Mikami T, Hosooka T, Inoue H, Matsumoto M, Koike M, Uchiyama Y, Noda T, Seino S, Kasuga M, Kido Y.

PLoS One. 2011;6(8):e23238. doi: 10.1371/journal.pone.0023238. Epub 2011 Aug 19.

48.

Overexpression of KLF15 transcription factor in adipocytes of mice results in down-regulation of SCD1 protein expression in adipocytes and consequent enhancement of glucose-induced insulin secretion.

Nagare T, Sakaue H, Matsumoto M, Cao Y, Inagaki K, Sakai M, Takashima Y, Nakamura K, Mori T, Okada Y, Matsuki Y, Watanabe E, Ikeda K, Taguchi R, Kamimura N, Ohta S, Hiramatsu R, Kasuga M.

J Biol Chem. 2011 Oct 28;286(43):37458-69. doi: 10.1074/jbc.M111.242651. Epub 2011 Aug 23.

49.

Role of S6K1 in regulation of SREBP1c expression in the liver.

Li S, Ogawa W, Emi A, Hayashi K, Senga Y, Nomura K, Hara K, Yu D, Kasuga M.

Biochem Biophys Res Commun. 2011 Aug 26;412(2):197-202. doi: 10.1016/j.bbrc.2011.07.038. Epub 2011 Jul 22.

PMID:
21806970
50.

[Trend of basic researches for the metabolic syndrome].

Kasuga M.

Nihon Rinsho. 2011 Jan;69 Suppl 1:20-5. Review. Japanese. No abstract available.

PMID:
21766568

Supplemental Content

Loading ...
Support Center